Boston Scientific launches Promus

AuntMinnie.com staff writers
Jan 10, 2007

Interventional device developer Boston Scientific said that it has initiated international marketing of its Promus everolimus-eluting stent.

Promus is a private-label version of the Xience V everolimus-eluting coronary stent, which is manufactured by Abbott Vascular of Redwood City, CA, and distributed by Boston Scientific, according to the Natick, MA-based firm.

The stent received CE Mark approval in October 2006, which allows Boston Scientific to distribute the stent in select countries of the European Economic Area. It will also be available in selected countries in Asia, Latin America, and Eastern Europe. A U.S. launch is planned for 2008, the company said.

By AuntMinnie.com staff writers
January 11, 2007

Related Reading

Boston Scientific buys EndoTex, January 4, 2007

Boston Scientific receives FDA nod for FilterWire EZ, December 14, 2006

Boston Scientific, GE integrate informatics apps, November 9, 2006

Boston to bring Liberte to Japan, November 6, 2006

Abbott launches Xience V stent, October 3, 2006

Copyright © 2007 AuntMinnie.com

Latest in Interventional
Ge Hc Logo 65d4f2455225b
GE HealthCare and Medis collaborate on cath lab software
May 14, 2024
A case presented at the ARRS annual meeting shows the results of successful microwave ablation (MWA) treatment for a 39-year-old female with metastatic fibrosarcoma of the right axillary sinus.
ARRS: MWA safe, effective method to treat bone metastases
May 10, 2024
Stroke Skull Xray 400
Can ChatGPT ‘data mine’ patient reports for stroke registries?
April 19, 2024
Gavel3
Abortion care limitations raise medicolegal concerns in IR
April 3, 2024
Related Stories
2006 09 18 13 51 52 706
Interventional
Student-designed CT-guided biopsy device shows early promise
2006 07 03 13 10 14 706
Interventional
Catheter securement devices win favor in reducing infection from PICC lines
2006 05 01 14 27 03 706
Interventional
Vertebroplasty increases vertebral height, imaging shows
2005 11 28 00 10 25 706
Interventional
Mammary Rosai-Dorfman mimics malignancy on imaging, biopsy reveals truth
More in Interventional
GE HealthCare and Medis collaborate on cath lab software
By AuntMinnie.com staff writers
GE HealthCare and Medis Medical Imaging will collaborate on developing and commercializing software for diagnosing and treating coronary artery disease.
May 14, 2024
Ge Hc Logo 65d4f2455225b
ARRS: MWA safe, effective method to treat bone metastases
By Amerigo Allegretto
Ultrasound-guided microwave ablation (MWA) is a safe, effective method for treating bone metastases.
May 10, 2024
A case presented at the ARRS annual meeting shows the results of successful microwave ablation (MWA) treatment for a 39-year-old female with metastatic fibrosarcoma of the right axillary sinus.
Can ChatGPT ‘data mine’ patient reports for stroke registries?
By Will Morton
ChatGPT-4 appears useful for extracting details from reports on thrombectomy procedures in stroke patients, a labor-intensive and error-prone task currently performed by human readers.
April 19, 2024
Stroke Skull Xray 400
Abortion care limitations raise medicolegal concerns in IR
By Will Morton
Interventional radiology (IR) specialists should be aware of shifting individual state laws on abortion so as to not be blindsided when called on to provide care to pregnant patients.
April 3, 2024
Gavel3
Can Chat GPT accurately refer patients to IR for treatment?
By Chloe G. Cross, MD
In interventional radiology (IR), most of us quickly become accustomed to needing to explain what we do. But how do patients get their own information about IR, if at all?
April 1, 2024
Interventional Radiology
Cryoablation effective in women with breast cancer
By Will Morton
A minimally invasive procedure called cryoablation that uses ice to freeze and destroy tumors has proven effective for women with large breast cancer tumors.
March 27, 2024
Breast Update
How has virtual interviewing impacted residency matches?
By Will Morton
Virtual interviews implemented due to the COVID-19 pandemic do not appear to have shifted the geographic distribution of interventional and diagnostic radiology residents.
March 26, 2024
Residents
MRI/ultrasound combination effective for treating prostate cancer
By Kate Madden Yee
A new, minimally invasive procedure that combines MRI and transurethral ultrasound ablation is effective for treating prostate cancer, according to recent research.
March 21, 2024
Prostate Cancer
Hysterectomies may be averted with UAE
By Will Morton
A minimally invasive treatment called uterine artery embolization (UAE) may be a promising alternative to hysterectomy in women due to severe bleeding after childbirth.
March 20, 2024
Uae
Coronary angiography matches IVUS in guiding PCI stent implantation
By Amerigo Allegretto
Intravascular ultrasound (IVUS) is on par with quantitative coronary angiography when it comes to guiding stent implantation.
March 13, 2024
Heart Scan 400
CEUS shines in diagnostic, interventional settings
By Amerigo Allegretto
Contrast-enhanced ultrasound (CEUS) is a problem-solving tool useful in interventions, according to a presentation given at ECR 2024.
March 6, 2024
Screenshot (1117) (1)
EVT valuable in patients requiring transit to stroke centers
By Will Morton
Endovascular thrombectomy (EVT) is effective for stroke patients who need to be transferred from hospitals where they are diagnosed to centers capable of performing the procedure.
February 9, 2024
Ambulance
Page 1 of 180
Next Page